Related Experiment Video
Updated: Jun 3, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
[To grow up with Crohn's disease]
Judit Kovács1, Anikó Nagy, András Szabó
1Fővárosi Önkormányzat Heim Pál Gyermekkórháza Gasztroenterológiai és Nefrológiai Osztály, Budapest. birokovacs@hdsnet.hu
Childhood-onset Crohn's disease in Hungary shows characteristics similar to other European countries. Early immunomodulatory therapy is key for favorable outcomes in pediatric Crohn's disease patients.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Epidemiology
Context:
- Crohn's disease (CD) is a chronic inflammatory bowel disease.
- Childhood-onset CD presents unique challenges in diagnosis and management.
- Understanding disease characteristics in specific populations is crucial for effective treatment strategies.
Purpose:
- To characterize the clinical features and disease course of childhood-onset Crohn's disease in Hungarian patients.
- To identify factors influencing disease progression and treatment outcomes.
- To compare Hungarian pediatric CD patients with international cohorts.
Summary:
- A retrospective review of 81 Hungarian patients with childhood-onset Crohn's disease (diagnosed before age 18) was conducted.
- Key findings include a male predominance (62%), significant diagnostic lag (11.36 months), and high initial disease activity.
- Common initial manifestations included ileal involvement (87%), stricturing/penetrating disease (27%), and malnutrition (23.5%).
- Treatment involved steroids (84%) and azathioprine (62%); biologic therapy was unavailable.
- At age 18, disease activity, malnutrition, and growth failure significantly improved, with 31% undergoing surgery.
Impact:
- This study highlights that childhood-onset Crohn's disease in Hungary shares similarities with European cohorts.
- Prolonged diagnostic delays and high initial disease burden necessitate aggressive early therapeutic approaches.
- The findings underscore the importance of early immunomodulatory therapy for improving long-term outcomes in pediatric Crohn's disease.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease I: Introduction

